Cargando…

Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms

Detalles Bibliográficos
Autores principales: Nguyen, Tri, Parker, Rebecca, Hawkins, Elisa, Holkova, Beata, Yazbeck, Victor, Kolluri, Akhil, Kmieciak, Maciej, Rahmani, Mohamed, Grant, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731100/
https://www.ncbi.nlm.nih.gov/pubmed/31523396
http://dx.doi.org/10.18632/oncotarget.27175
_version_ 1783449632099008512
author Nguyen, Tri
Parker, Rebecca
Hawkins, Elisa
Holkova, Beata
Yazbeck, Victor
Kolluri, Akhil
Kmieciak, Maciej
Rahmani, Mohamed
Grant, Steven
author_facet Nguyen, Tri
Parker, Rebecca
Hawkins, Elisa
Holkova, Beata
Yazbeck, Victor
Kolluri, Akhil
Kmieciak, Maciej
Rahmani, Mohamed
Grant, Steven
author_sort Nguyen, Tri
collection PubMed
description
format Online
Article
Text
id pubmed-6731100
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-67311002019-09-13 Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms Nguyen, Tri Parker, Rebecca Hawkins, Elisa Holkova, Beata Yazbeck, Victor Kolluri, Akhil Kmieciak, Maciej Rahmani, Mohamed Grant, Steven Oncotarget Correction Impact Journals LLC 2019-09-03 /pmc/articles/PMC6731100/ /pubmed/31523396 http://dx.doi.org/10.18632/oncotarget.27175 Text en Copyright: © 2019 Nguyen et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Nguyen, Tri
Parker, Rebecca
Hawkins, Elisa
Holkova, Beata
Yazbeck, Victor
Kolluri, Akhil
Kmieciak, Maciej
Rahmani, Mohamed
Grant, Steven
Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms
title Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms
title_full Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms
title_fullStr Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms
title_full_unstemmed Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms
title_short Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms
title_sort correction: synergistic interactions between plk1 and hdac inhibitors in non-hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731100/
https://www.ncbi.nlm.nih.gov/pubmed/31523396
http://dx.doi.org/10.18632/oncotarget.27175
work_keys_str_mv AT nguyentri correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms
AT parkerrebecca correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms
AT hawkinselisa correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms
AT holkovabeata correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms
AT yazbeckvictor correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms
AT kolluriakhil correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms
AT kmieciakmaciej correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms
AT rahmanimohamed correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms
AT grantsteven correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms